EMT in cancer

被引:1570
作者
Brabletz, Thomas [1 ]
Kalluri, Raghu [2 ]
Angela Nieto, M. [3 ]
Weinberg, Robert A. [4 ,5 ]
机构
[1] FAU Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr Mol Med, Dept Expt Med 1, Gluckstr 6, D-91054 Erlangen, Germany
[2] Univ Texas MD Anderson Canc Ctr, Metastasis Res Ctr, Dept Canc Biol, Houston, TX 77054 USA
[3] CSIC UMH, Inst Neurociencias, Avda Ramon y Cajal S-N, Alacant 03550, Spain
[4] Ludwig Massachusetts Inst Technol MIT, Ctr Mol Oncol, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA
[5] MIT, Dept Biol, Cambridge, MA 02142 USA
基金
欧洲研究理事会;
关键词
EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-INITIATING CELLS; BREAST-CANCER; PANCREATIC-CANCER; CELLULAR PLASTICITY; DRUG-RESISTANCE; LUNG METASTASIS; STEM-CELLS; E-CADHERIN; ZEB1;
D O I
10.1038/nrc.2017.118
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Similar to embryonic development, changes in cell phenotypes defined as an epithelial to mesenchymal transition (EMT) have been shown to play a role in the tumorigenic process. Although the first description of EMT in cancer was in cell cultures, evidence for its role in vivo is now widely reported but also actively debated. Moreover, current research has exemplified just how complex this phenomenon is in cancer, leaving many exciting, open questions for researchers to answer in the future. With these points in mind, we asked four scientists for their opinions on the role of EMT in cancer and the challenges faced by scientists working in this fast-moving field.
引用
收藏
页码:128 / +
页数:7
相关论文
共 61 条
  • [41] Ombrato Luigi, 2014, Critical Reviews in Oncogenesis, V19, P349
  • [42] Oncogenic roles of EMT-inducing transcription factors
    Puisieux, Alain
    Brabletz, Thomas
    Caramel, Julie
    [J]. NATURE CELL BIOLOGY, 2014, 16 (06) : 488 - 494
  • [43] Tracking and Functional Characterization of Epithelial-Mesenchymal Transition and Mesenchymal Tumor Cells during Prostate Cancer Metastasis
    Ruscetti, Marcus
    Quach, Bill
    Dadashian, Eman L.
    Mulholland, David J.
    Wu, Hong
    [J]. CANCER RESEARCH, 2015, 75 (13) : 2749 - 2759
  • [44] Tumour-promoting role of EMT-inducing transcription factor ZEB1 in mantle cell lymphoma
    Sayan, A. E.
    [J]. CELL DEATH AND DIFFERENTIATION, 2014, 21 (02) : 194 - 195
  • [45] Adhesion in Mammary Development: Novel Roles for E-Cadherin in Individual and Collective Cell Migration
    Shamir, Eliah R.
    Ewald, Andrew J.
    [J]. CELLULAR ADHESION IN DEVELOPMENT AND DISEASE, 2015, 112 : 353 - 382
  • [46] Overexpression of ZEB1 relates to metastasis and invasion in osteosarcoma
    Shen, Aidong
    Zhang, Yunqing
    Yang, Huiguang
    Xu, Ruisheng
    Huang, Guowei
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 2012, 105 (08) : 830 - 834
  • [47] EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
    Shibue, Tsukasa
    Weinberg, Robert A.
    [J]. NATURE REVIEWS CLINICAL ONCOLOGY, 2017, 14 (10) : 611 - 629
  • [48] Epithelial-to-Mesenchymal Transition: Epigenetic Reprogramming Driving Cellular Plasticity
    Skrypek, Nicolas
    Goossens, Steven
    De Smedt, Eva
    Vandamme, Niels
    Berx, Geert
    [J]. TRENDS IN GENETICS, 2017, 33 (12) : 943 - 959
  • [49] Son H, 2010, TOX RESEARCH, V26, P245, DOI 10.5487/TR.2010.26.4.245
  • [50] MLL-AF9 Expression in Hematopoietic Stem Cells Drives a Highly Invasive AML Expressing EMT-Related Genes Linked to Poor Outcome
    Stavropoulou, Vaia
    Kaspar, Susanne
    Brault, Laurent
    Sanders, Mathijs A.
    Juge, Sabine
    Morettini, Stefano
    Tzankov, Alexandar
    Iacovino, Michelina
    Lau, I-Jun
    Milne, Thomas A.
    Royo, Helene
    Kyba, Michael
    Valk, Peter J. M.
    Peters, Antoine H. F. M.
    Schwaller, Juerg
    [J]. CANCER CELL, 2016, 30 (01) : 43 - 58